Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84

An Esp Pediatr. 1988 Oct:29 Suppl 34:72-83.
No abstract available

MeSH terms

  • Adolescent
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Asparaginase / administration & dosage
  • Asparaginase / therapeutic use
  • Child
  • Child, Preschool
  • Clinical Protocols
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use
  • Daunorubicin / administration & dosage
  • Daunorubicin / therapeutic use
  • Female
  • Humans
  • Infant
  • Male
  • Mercaptopurine / therapeutic use
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use
  • Vincristine / administration & dosage
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Cytarabine
  • Vincristine
  • Prednisolone
  • Mercaptopurine
  • Asparaginase
  • Methotrexate
  • Daunorubicin